Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
21 Pages - GLDATA51007
$250.00

Summary

Navamedic ASA (Navamedic), formerly Glucomed AS, is a speciality pharmaceutical products company, which markets and distributes more than 120 products in the Nordic and Benelux markets. The company undertakes the in-licensing and sale of pharmaceuticals and other health care products. Its product portfolio includes a wide range of generics and specialty pharmaceuticals, medical devices, food supplements and other products in the healthcare domain. Navamedic operates business in three segments, namely, Pharma, Medical Nutrition and Consumer Care. The Pharma segment involves the generics business covering prescription drugs that are sold in pharmacies and hospitals. This segment operates through the company’s subsidiary, Navamedic AB and markets generic pharmaceuticals for the treatment of anesthesia, oral medicine, gastro, female care, neurology, dermatology, osteoarthritis, oncology and other diseases. The Medical Nutrition segment markets nutritional products for inborn errors of metabolism.; and its Consumer Care segment offers non-prescription drugs, healthcare products and medical devices. The company has its operational presence in Sweden, Denmark, Benelux, Norway, Netherlands, Belgium, Iceland and Finland. Navamedic is headquartered in Lysaker, Oslo, Norway.

Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Navamedic ASA, Medical Devices Deals, 2010 to YTD 2016 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Navamedic ASA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 11
Navamedic Amends Distribution Agreement With Aspen Pharma 12
Navamedic Enters Into Distribution Agreement With Torrent Pharma 13
Vitaflo Scandinavia Enters Into Distribution Agreement With Angelini Group 14
Vitaflo Scandinavia Enters Into Co-Marketing Agreement With Smartfish 15
Navamedic Enters Into Distribution Agreement With Aspen Pharma 16
Vitaflo Scandinavia Enters Into Distribution Agreement With Ponsus Pharma For Proderm Hud 17
Navamedic ASA - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Navamedic ASA, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Navamedic ASA, Deals By Therapy Area, 2010 to YTD 2016 8
Navamedic ASA, Medical Devices Deals, 2010 to YTD 2016 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 11
Navamedic Amends Distribution Agreement With Aspen Pharma 12
Navamedic Enters Into Distribution Agreement With Torrent Pharma 13
Vitaflo Scandinavia Enters Into Distribution Agreement With Angelini Group 14
Vitaflo Scandinavia Enters Into Co-Marketing Agreement With Smartfish 15
Navamedic Enters Into Distribution Agreement With Aspen Pharma 16
Vitaflo Scandinavia Enters Into Distribution Agreement With Ponsus Pharma For Proderm Hud 17
Navamedic ASA, Key Competitors 18
Navamedic ASA, Key Employees 19
Navamedic ASA, Subsidiaries 20

List of Figures
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Navamedic ASA, Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838